Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmanovia A/S
A/S
Active
Advertising protection
CVR 32287824
Ørestads Boulevard 108, 2300
København S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2009 · 16 years old
4 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pharmanovia A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
13M
25M
38M
51M
15M
2021
3M
2022
44M
2023
5M
2024
6M
2025
EBITDA
DKK millions
33M
21M
9M
-3M
-15M
-1M
2021
-12M
-1100%
2022
26M
+317%
2023
3M
-88%
2024
4M
+33%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
15.224
3.431
43.984
4.684
6.025
Staff expenses
-15.840
-15.917
-18.458
-1.607
-2.172
EBITDA
-617
-12.485
25.526
3.077
3.852
Depreciation & amort.
-1.183
-7.651
-601
-152
-148
EBIT
-1.799
-20.136
24.924
2.925
3.704
Net financials
-229
-1.464
-469
-243
128
Profit before tax
-2.028
-21.600
24.455
2.683
3.832
Tax
-0
-0
-1.676
436
-7
Net profit
-2.028
-21.600
26.131
2.247
3.839
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
27.912
76.094
136.728
47.728
39.941
Equity
15.110
-6.491
19.640
4.883
8.090
Long-term debt
3.251
60.708
38.340
0
0
Short-term debt
9.551
21.877
78.748
42.844
31.576
Total debt
12.803
82.585
117.088
42.844
31.576
Financial ratios
5-year trend
EBITDA margin (of gross profit)
63.9%
This company
2021
2025
Equity ratio
20.3%
This company
38.2%
Market median
-47% vs market
2021
2025
Return on equity
47.5%
This company
18.4%
Market median
+158% vs market
2021
2025
Net profit margin (of gross profit)
63.7%
This company
2021
2025
Asset turnover (of gross profit)
0.15×
This company
2021
2025
Debt / equity
3.94×
This company
0.62×
Market median
-535% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
View
PDF
More on Pharmanovia A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
